Literature DB >> 11381258

Failure to confirm NOTCH4 association with schizophrenia in a large population-based sample from Scotland.

R E McGinnis1, H Fox, P Yates, L A Cameron, M R Barnes, I C Gray, N K Spurr, O Hurko, D St Clair.   

Abstract

The NOTCH4 gene was recently reported to be associated with schizophrenia based on TDT analysis of 80 British trios. The strongest evidence for association derived from two microsatellites. We genotyped both loci in a large sample of unrelated Scottish schizophrenics and controls, but failed to replicate the reported association, finding instead that each putative schizophrenia-associated allele had a somewhat lower frequency in schizophrenics than in controls.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11381258     DOI: 10.1038/88839

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  4 in total

Review 1.  Imaging phenotypes and genotypes in schizophrenia.

Authors:  Jessica A Turner; Padhraic Smyth; Fabio Macciardi; James H Fallon; James L Kennedy; Steven G Potkin
Journal:  Neuroinformatics       Date:  2006

2.  Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata.

Authors:  R Tazi-Ahnini; M J Cork; D Wengraf; A G Wilson; D J Gawkrodger; M P Birch; A G Messenger; A J G McDonagh
Journal:  Hum Genet       Date:  2003-02-14       Impact factor: 4.132

3.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia.

Authors:  Richard E Straub; Yuxin Jiang; Charles J MacLean; Yunlong Ma; Bradley T Webb; Maxim V Myakishev; Carole Harris-Kerr; Brandon Wormley; Hannah Sadek; Bharat Kadambi; Anthony J Cesare; Avi Gibberman; Xu Wang; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler
Journal:  Am J Hum Genet       Date:  2002-07-03       Impact factor: 11.025

4.  Regulation of striatal dopamine responsiveness by Notch/RBP-J signaling.

Authors:  M Toritsuka; S Kimoto; K Muraki; M Kitagawa; T Kishimoto; A Sawa; K Tanigaki
Journal:  Transl Psychiatry       Date:  2017-03-07       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.